The exosomal Rab22a-NeoF1 fusion protein functions in its negative recipient cells, such as activation of RhoA and Stat3 in cancer cells and macrophages, respectively, which is dependent on its binding partner PYK2 from its positive donor cells. This evidence concerns the gene RAB22A and cancer.